Learning Documentation Lessons from FDA/EMA Inspections
ACRP is organizing an online teaching session about regulatory inspections, to be held on May 14, 2014.
The Association of Clinical Research Professionals (ACRP) is organizing an online teaching session about regulatory inspections, to be held on May 14, 2014.
The event will examine common findings from inspections by the Food and Drug Administration (FDA) and European Medicines Agency (EMA). The plan is to use a “lessons learned” approach to help identify and prevent common inspection findings related to essential document collection and retention.
According to a statement from the organizers, “This Webinar delves into essential document collection and retention by first identifying what essential documents are and why they are necessary. The presenter will then cover essential document requirements and responsibilities in clinical research, followed by essential document retention requirements.”
Also, the program will cover any differences between ICH/GCP, FDA, and the EU Clinical Trials Directive in the requirements and retention of essential documents.
The event is designed for experienced research nurses, investigators, research assistants, research associates, project managers and all other staff who are directly involved in performing clinical research who are familiar with the terminology. The presenter will be Judith van Heel, who formerly worked for Bristol Myers-Squibb and Novartis and CROs Kendle International and JCR).
The event will take place from 12 noon to 1.30 pm US Eastern Time. The cost of registration is $99 for members and $149 for non-members.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
